IL86876A0 - Polypeptides,their preparation and pharmaceutical composition containing them - Google Patents

Polypeptides,their preparation and pharmaceutical composition containing them

Info

Publication number
IL86876A0
IL86876A0 IL86876A IL8687688A IL86876A0 IL 86876 A0 IL86876 A0 IL 86876A0 IL 86876 A IL86876 A IL 86876A IL 8687688 A IL8687688 A IL 8687688A IL 86876 A0 IL86876 A0 IL 86876A0
Authority
IL
Israel
Prior art keywords
polypeptides
preparation
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
IL86876A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL86876A0 publication Critical patent/IL86876A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL86876A 1987-06-29 1988-06-27 Polypeptides,their preparation and pharmaceutical composition containing them IL86876A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
IL86876A0 true IL86876A0 (en) 1988-11-30

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86876A IL86876A0 (en) 1987-06-29 1988-06-27 Polypeptides,their preparation and pharmaceutical composition containing them

Country Status (15)

Country Link
JP (1) JPS6426599A (enExample)
KR (1) KR890000520A (enExample)
AU (1) AU1840988A (enExample)
BE (1) BE1002663A4 (enExample)
CH (1) CH679045A5 (enExample)
DK (1) DK353788A (enExample)
ES (1) ES2010283A6 (enExample)
FR (1) FR2617171B1 (enExample)
GB (1) GB2206352B (enExample)
IL (1) IL86876A0 (enExample)
IT (1) IT1221065B (enExample)
LU (1) LU87262A1 (enExample)
NL (1) NL8801640A (enExample)
NZ (1) NZ225188A (enExample)
SE (1) SE8802413L (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
CA2053250A1 (en) * 1989-04-26 1990-10-27 David H. Coy Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
CA2385910A1 (en) * 2000-07-31 2002-02-07 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
DK1372688T3 (da) 2001-03-08 2008-08-25 Univ Tulane Somatostatin-antagonister
CN1541102A (zh) * 2001-04-09 2004-10-27 生长激素抑制素激动剂
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
JPS6426599A (en) 1989-01-27
GB2206352B (en) 1990-10-31
FR2617171B1 (fr) 1994-10-14
DK353788D0 (da) 1988-06-27
LU87262A1 (fr) 1989-03-08
BE1002663A4 (fr) 1991-04-30
CH679045A5 (enExample) 1991-12-13
DK353788A (da) 1988-12-30
IT1221065B (it) 1990-06-21
ES2010283A6 (es) 1989-11-01
NL8801640A (nl) 1989-01-16
GB2206352A (en) 1989-01-05
FR2617171A1 (fr) 1988-12-30
KR890000520A (ko) 1989-03-15
SE8802413D0 (sv) 1988-06-28
NZ225188A (en) 1991-04-26
AU1840988A (en) 1989-01-05
GB8815257D0 (en) 1988-08-03
SE8802413L (sv) 1988-12-30
IT8848133A0 (it) 1988-06-28

Similar Documents

Publication Publication Date Title
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
IL79323A (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
IL84723A0 (en) Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them
IL95155A0 (en) 1h-indazole-3-carboxamides,their preparation and pharmaceutical compositions containing them
IL95640A0 (en) 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL79309A0 (en) (heterocyclic substituted-phenoxy)alkyl-isoxazoles and-furans,their preparation and pharmaceutical compositions containing them
IL84302A0 (en) Substituted alpha-aminoacids,their preparation and pharmaceutical compositions containing them
IL94556A0 (en) Hydroxypropylamines,their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL86033A0 (en) Substituted pyrroles,their preparation and pharmaceutical compositions containing them
IL85885A0 (en) Cyclic peptides,their preparation and pharmaceutical compositions containing them
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL91709A0 (en) Substituted thienopyrans,their preparation and pharmaceutical compositions containing them
IL86478A0 (en) Substituted vinylcephalosporins,their preparation and pharmaceutical compositions containing them
IL92326A0 (en) Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them
IL91003A0 (en) Proteins,their production and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
IL88934A0 (en) Recombinant human interleukin-1alpha polypeptides,their preparation and pharmaceutical compositions containing them
IL99009A0 (en) Polypeptides,their preparation and pharmaceutical compositions containing them
IL83101A0 (en) Substituted hexahydro arylquinolizines,their preparation and pharmaceutical compositions containing them
IL84509A0 (en) Pyrrolo-benzimidazoles,their preparation and pharmaceutical composition containing them
GB2196958B (en) Halo-homostatin peptide derivatives ,their preparation and pharmaceutical compositions containing them
IL88658A0 (en) 8,9-annelated beta-carbolines and 3,4-dihydro-beta-carbolines,their preparation and pharmaceutical compositions containing them